GOSS compared with INAB: revenue, margins and what each company keeps, and the suppliers and customers both name

GOSSGossamer Bio, Inc.

Mkt capRevenueRevenue

INABIN8BIO, Inc.

Mkt capRevenueRevenue

Compare

GOSSGossamer Bio, Inc.

INABIN8BIO, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

GOSS

0 of 4at or beyond implied

Reportimpliedrealized× implied

Aug 14 '26±71.9%▼−9.45%×0.13

Q2 FY26±51.0%▼−43.32%×0.85

Q1 FY26±22.4%▼−7.99%×0.36

Q3 FY25±26.7%▼−2.53%×0.09

INAB1 of 4 reports

Reportimpliedrealized× implied

Q2 FY26—▲+0.90%—

= impliedGOSS realized, solidINAB realized, hatchedOne scale, both sides: full bar = 72%× = |realized| ÷ impliedSource: market data

GOSSGossamer Bio, Inc.

10.35▼−3.17%· post 10.20

Mkt cap$63.4MRevenue$9MQ2 FY26Revenue$48MFY25

INABIN8BIO, Inc.

0.94▼−4.09%· post 0.94

ClosedOct 30 '26

Mkt cap$8.9MRevenue—Revenue—

Compare

ClosedOct 30 '26

GOSSGossamer Bio, Inc.

INABIN8BIO, Inc.

10.35▼−3.17%post 10.20

Price

0.94▼−4.09%post 0.94

$63.4M

Mkt cap

$8.9M

Q2 FY26$9M

Revenue

—

FY25$48M

Revenue

—

GOSS10.35▼−3.17%vsINAB0.94▼−4.09%ClosedOct 30 '26